Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

7 Stocks to Buy for the Long Run

Stocks in companies that deliver long-term success are still the secret to wealth accumulation

Tesla Is Overvalued for a Car Company, But It’s Much More Than That

Tesla is seen as dominating tomorrow's market for electricity and telecommunications, as well as capturing profit from every service its cars need.

Albemarle Investors Float Higher on Lithium Bubble

Albemarle hopes to double its lithium production over the next five years. ALB stock appears to have gained on expectations of battery demand.

AT&T Stock: Money for Bits

AT&T is being discounted by investors becuase of its video holdings and growing competition. But it's still in prime position to profit from 5G and the Machine Internet.

Put Your Money Elsewhere While the Speculators Fight Over Luckin Stock

I don't trust either side of this trade and that's what it is. The shorts are being squeezed, and the management looks dodgy.

How to Ride the Covid-19 Bull with Moderna

MRNA has won the Covid-19 vaccine race and could bring in $11.7 billion with its candidate in 2021. But is Moderna stock overpriced?

There’s Simply Nothing Wrong With Microsoft

Coming off a stellar earnings report and with strong leadership at the helm, MSFT stock is a force to be reckoned with.

Amazon Stock Can Afford To Have Some Failures

Misfires like the Whole Foods acquisition won't slow down Amazon stock, which remains a global e-commerce juggernaut and cloud juggernaut.

Lowes Stock Is a Buy as Ellison Shows That He Knows Home Improvement

Lowe's has been gaining share against Home Depot, especially online, as both home improvement stocks glided through the pandemic.

Why Are Investors Piling in on Granite Construction?

GVA stock has been rising on the Democrats gaining control, but past accounting issues should make investors question the enthusiasm.